Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Australie349
John D. O'Sullivan18
Australie Sauf John D. O'Sullivan" 334
John D. O'Sullivan Sauf Australie" 3
Australie Et John D. O'Sullivan 15
Australie Ou John D. O'Sullivan 352
Corpus10303
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000395 Nadeeka N N W. Dissanayaka [Australie] ; Elizabeth White ; John D. O'Sullivan ; Rodney Marsh ; Nancy A. Pachana ; Gerard J. ByrneThe clinical spectrum of anxiety in Parkinson's disease.
001C16 Alberto J. Espay [États-Unis] ; Dominic C. Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Robert E. Schmidt [États-Unis] ; Fredy J. Revilla [États-Unis] ; Leo Verhagen Metman [États-Unis] ; David Williams [États-Unis, Royaume-Uni, Australie]Juvenile levodopa‐responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment
001E48 Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; Rodney Marsh [Australie] ; George D. Mellick [Australie]Anxiety disorders in Parkinson's disease: Prevalence and risk factors
001E90 Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande]A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
001F92 Nadeeka N. W. Dissanayaka [Australie] ; Annabelle N. Sellebach [Australie] ; Sally Matheson [Australie] ; Rodney Marsh [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; George D. Mellick [Australie]Validity of a self‐rated method to identify a lifetime history of depression in Parkinson's disease
002058 Nadeeka N. W. Dissanayaka [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie]Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease
002281 Greg T. Sutherland [Australie] ; Gerhard A. Siebert [Australie] ; Jeremy R. B. Newman [Australie] ; Peter A. Silburn [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie]Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease
002351 Greg T. Sutherland [Australie] ; Glenda M. Halliday [Australie] ; Peter A. Silburn [Australie] ; Frank L. Mastaglia [Australie] ; Dominic B. Rowe [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; Tina Ly [Australie] ; Steve D. Wilton [Australie] ; George D. Mellick [Australie]Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
002B05 Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; Rodney Marsh [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; Gerard J. Byrne [Australie] ; George D. Mellick [Australie]Validity of Hamilton depression inventory in Parkinson's disease
002D15 Kerrie L. Schoffer [Australie] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie]Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
003516 Kerrie L. Schoffer [Australie] ; John D. O'Sullivan [Australie] ; Jim Mcgill [Australie]Congenital disorder of glycosylation type Ia presenting as early‐onset cerebellar ataxia in an adult
003B76 Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Silke Appel [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
003C63 Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
004F99 John D. O'Sullivan [Australie] ; Catherine M. Said [Australie] ; Louise C. Dillon [Australie] ; Marion Hoffman [Australie] ; Hughes [Australie]Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function
005069 John D. O'Sullivan [Australie] ; Andrew J. Hughes [Australie]Apomorphine‐induced penile erections in Parkinson's disease
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024